3652 results for «238»

Filter By

3652 results

STEMI and unusual thrombus

16 May 2023 – From EuroPCR 2023

If you'd like to deepen your understanding of complications in ST-segment elevation myocardial infarction, join the speakers as they present a series of cases focusing on atypical thrombus formation.

STEMI and unusual thrombus

Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!

17 May 2023 – From EuroPCR 2023

Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.

Heterotopic valve replacement

Complex PCI in high bleeding risk patients: adjust your strategy!

17 May 2023 – From EuroPCR 2023

With the guidance of a live case from the Clinique Pasteur in Toulouse - multivessel PCI in a patient at high bleeding risk- and the latest results from the MASTER DAPT randomized trial that enrolled patients treated exclusively with the Ultimater stent, the presenters invite us...

Complex PCI in high bleeding

When dissection occurs during primary PCI

16 May 2023 – From EuroPCR 2023

Discover the complexities surrounding dissection during primary percutaneous coronary intervention (PCI). Immerse yourself in the challenges, implications and strategies employed to manage this critical scenario skillfully.

When dissection occurs during primary PCI

More pulses to take you further across all calcium morphologies

17 May 2023 – From EuroPCR 2023

Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!

More pulses to take you

The future of physiology- and morphology-guided PCI is optical!

17 May 2023 – From EuroPCR 2023

Join this session to explore the advantages of a fully optical approach in optimizing percutaneous coronary intervention (PCI) with the OptoWire III physiology wire and Nipro HF-OCT catheter. Through a practical case, you'll discover the significance of coronary physiology and intravascular imaging in bifurcation PCI and...

The future of physiology-

Calcified lesions: how to treat

16 May 2023 – From EuroPCR 2023

Learn more about the treatment of calcified lesions in this session, where speakers dissect a collection of cases focusing on tough situations.

Calcified lesions: how to treat

Making treatment and management of complex PCIs easier with Cre8 EVO

17 May 2023 – From EuroPCR 2023

Maximize patient clinical outcomes in complex percutaneous coronary interventions (PCIs) by joining this session. Discover how accurate patient evaluation, advanced imaging/functional modalities, optimized procedures, and the Cre8 EVO device contribute to improved safety and efficacy, and review the challenges associated with DES implantation in complex PCIs.

Making treatment and

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial

09 Nov 2022

Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected coronary artery disease: the PRECISE randomized trial
Didn’t find what you were looking for?